Stock listing
NASDAQ:CTOR Citius Oncology, Inc. Stock
Home listing (NASDAQ) of Citius Oncology, Inc.
Follow Citius Oncology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CTOR
$0.554 USD +0.025 (+4.6%)
Close on Oct 30, 2026
- Day range
- $0.500 – $0.563 USDOct 30, 2026
- Volume
- 283,279 sharesOct 30, 2026
- Market cap
- $58.59M USDAt the close on Oct 30, 2026 · price × 105.8M shares outstanding
- 52-week range
- $0.491 – $1.830 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $94,476 USDMedian day 70,767 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CTOR · Home | $0.554 USD | +0.025 (+4.6%) | 283,279 | $0.527 | $0.563 | $0.500 | $0.530 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CTOR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.554 | +0.025 | +4.6% | $0.527 | $0.563 | $0.500 | 283,279 | |
| $0.530 | -0.047 | -8.2% | $0.580 | $0.607 | $0.506 | 193,082 | |
| $0.577 | -0.034 | -5.6% | $0.629 | $0.629 | $0.571 | 91,806 | |
| $0.611 | +0.015 | +2.6% | $0.634 | $0.646 | $0.571 | 134,810 | |
| $0.596 | +0.016 | +2.8% | $0.612 | $0.689 | $0.539 | 874,207 | |
| $0.580 | -0.120 | -17.2% | $0.720 | $0.720 | $0.510 | 70,533 | |
| $0.700 | -0.001 | -0.1% | $0.729 | $0.730 | $0.655 | 38,020 | |
| $0.700 | +0.029 | +4.4% | $0.705 | $0.760 | $0.652 | 22,886 | |
| $0.671 | -0.039 | -5.5% | $0.730 | $0.747 | $0.660 | 97,444 | |
| $0.710 | -0.058 | -7.5% | $0.756 | $0.760 | $0.700 | 40,000 | |
| $0.768 | +0.022 | +2.9% | $0.770 | $0.770 | $0.750 | 11,700 | |
| $0.746 | -0.038 | -4.8% | $0.760 | $0.770 | $0.745 | 11,000 | |
| $0.784 | -0.008 | -1.0% | $0.811 | $0.811 | $0.750 | 27,600 | |
| $0.792 | -0.021 | -2.6% | $0.800 | $0.844 | $0.743 | 96,700 | |
| $0.813 | -0.027 | -3.2% | $0.860 | $0.860 | $0.780 | 67,900 | |
| $0.840 | +0.005 | +0.6% | $0.842 | $0.880 | $0.800 | 71,000 | |
| $0.835 | -0.016 | -1.9% | $0.870 | $0.870 | $0.820 | 56,400 | |
| $0.851 | +0.001 | +0.1% | $0.847 | $0.901 | $0.847 | 105,500 | |
| $0.850 | -0.024 | -2.7% | $0.858 | $0.920 | $0.812 | 109,800 | |
| $0.874 | -0.076 | -8.0% | $0.930 | $0.930 | $0.860 | 85,500 | |
| $0.950 | -0.030 | -3.1% | $0.999 | $1.050 | $0.914 | 208,400 | |
| $0.980 | -0.030 | -3.0% | $1.070 | $1.070 | $0.942 | 99,600 | |
| $1.010 | -0.040 | -3.8% | $1.090 | $1.090 | $1.000 | 96,700 | |
| $1.050 | +0.020 | +1.9% | $1.025 | $1.130 | $1.000 | 186,000 | |
| $1.030 | -0.020 | -1.9% | $1.040 | $1.080 | $1.020 | 43,600 | |
| $1.050 | 0.000 | 0.0% | $1.070 | $1.070 | $1.020 | 26,700 | |
| $1.050 | +0.040 | +4.0% | $1.030 | $1.080 | $1.007 | 40,700 | |
| $1.010 | -0.060 | -5.6% | $1.050 | $1.070 | $0.985 | 55,800 | |
| $1.070 | +0.025 | +2.4% | $1.000 | $1.120 | $1.000 | 117,000 | |
| $1.045 | -0.095 | -8.3% | $1.150 | $1.150 | $1.030 | 152,200 | |
| $1.140 | +0.120 | +11.8% | $1.050 | $1.155 | $1.010 | 336,900 | |
| $1.020 | +0.066 | +6.9% | $0.970 | $1.050 | $0.920 | 189,200 | |
| $0.954 | +0.098 | +11.4% | $0.890 | $0.984 | $0.853 | 184,400 | |
| $0.856 | -0.084 | -8.9% | $0.950 | $0.978 | $0.850 | 118,000 | |
| $0.940 | +0.022 | +2.4% | $0.920 | $0.988 | $0.915 | 69,200 | |
| $0.918 | +0.008 | +0.9% | $0.890 | $0.950 | $0.890 | 138,300 | |
| $0.910 | -0.030 | -3.2% | $0.920 | $0.940 | $0.868 | 47,900 | |
| $0.940 | +0.011 | +1.2% | $0.910 | $0.960 | $0.858 | 56,400 | |
| $0.929 | +0.069 | +8.0% | $0.913 | $0.940 | $0.872 | 220,800 | |
| $0.860 | +0.068 | +8.6% | $0.767 | $0.882 | $0.750 | 54,700 | |
| $0.792 | +0.014 | +1.8% | $0.800 | $0.800 | $0.778 | 13,900 | |
| $0.778 | +0.028 | +3.7% | $0.735 | $0.800 | $0.725 | 12,100 | |
| $0.750 | -0.013 | -1.7% | $0.770 | $0.777 | $0.725 | 16,600 | |
| $0.763 | -0.013 | -1.7% | $0.820 | $0.820 | $0.753 | 38,700 | |
| $0.776 | -0.014 | -1.8% | $0.800 | $0.800 | $0.754 | 21,700 | |
| $0.790 | +0.003 | +0.4% | $0.828 | $0.830 | $0.790 | 8,600 | |
| $0.787 | -0.023 | -2.8% | $0.791 | $0.820 | $0.752 | 17,000 | |
| $0.810 | +0.060 | +8.0% | $0.705 | $0.818 | $0.705 | 134,100 | |
| $0.750 | +0.006 | +0.8% | $0.759 | $0.760 | $0.722 | 16,600 | |
| $0.744 | -0.015 | -2.0% | $0.721 | $0.755 | $0.721 | 13,400 | |
| $0.759 | +0.006 | +0.8% | $0.752 | $0.773 | $0.710 | 52,100 | |
| $0.753 | +0.050 | +7.1% | $0.730 | $0.780 | $0.680 | 58,000 | |
| $0.703 | -0.037 | -5.0% | $0.718 | $0.718 | $0.659 | 86,500 | |
| $0.740 | -0.170 | -18.7% | $0.735 | $0.782 | $0.700 | 275,000 | |
| $0.910 | +0.083 | +10.0% | $0.827 | $0.935 | $0.801 | 297,200 | |
| $0.827 | +0.015 | +1.8% | $0.820 | $0.850 | $0.785 | 81,100 | |
| $0.812 | +0.082 | +11.2% | $0.725 | $0.814 | $0.707 | 59,300 | |
| $0.730 | -0.008 | -1.1% | $0.743 | $0.743 | $0.706 | 23,800 | |
| $0.738 | -0.015 | -2.0% | $0.760 | $0.760 | $0.716 | 75,000 | |
| $0.753 | -0.007 | -0.9% | $0.789 | $0.789 | $0.733 | 44,900 | |
| $0.760 | -0.025 | -3.2% | $0.795 | $0.795 | $0.710 | 179,400 | |
| $0.785 | +0.125 | +18.9% | $0.630 | $0.890 | $0.630 | 1,036,500 | |
| $0.660 | +0.035 | +5.6% | $0.679 | $0.680 | $0.640 | 74,100 | |
| $0.625 | +0.033 | +5.6% | $0.640 | $0.680 | $0.554 | 95,000 | |
| $0.592 | +0.018 | +3.1% | $0.598 | $0.603 | $0.587 | 39,600 | |
| $0.574 | +0.038 | +7.1% | $0.519 | $0.574 | $0.519 | 28,200 |
- Ticker
- NASDAQ:CTOR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Latest deck · Dec 1, 2025
Investor Presentation (December 2025)
Investor deck · 19 slides
Latest news
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Oct 26, 2026
Closed $0.596 (+2.8%) on Oct 26, 2026
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Oct 12, 2026
Closed $0.813 (-3.2%) on Oct 12, 2026
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026
Closed $0.74 (-18.7%) on Aug 17, 2026
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
Aug 12, 2026
Closed $0.812 (+11.2%) on Aug 12, 2026
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
Aug 5, 2026
Closed $0.785 (+18.9%) on Aug 5, 2026
Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption
Jul 21, 2026
Closed $0.57 (0.0%) on Jul 21, 2026
Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
Jun 1, 2026
Closed $0.792 (-0.8%) on Jun 1, 2026
Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
May 26, 2026
Closed $0.86 (+2.4%) on May 26, 2026
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
May 15, 2026
Closed $0.829 (-13.9%) on May 18, 2026
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
May 5, 2026
Closed $0.957 (+4.0%) on May 5, 2026
Decks
Investor Presentation (December 2025)
Investor deck · 19 slides · Dec 1, 2025
Investor Presentation (October 2025)
Investor deck · 19 slides · Oct 23, 2025
SPAC Merger (October 2023)
SPAC merger · 33 slides · Oct 24, 2023
Citius Oncology, Inc. on 6ix
- News releases
- 28 in the last 12 months · 66 in all · newest Oct 26, 2026 · oldest 2023
- Decks
- 3 decks · latest Dec 1, 2025
Where Citius Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CTOR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CTOR | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Citius Oncology, Inc.